The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP
- PMID: 1375324
- PMCID: PMC364460
- DOI: 10.1128/mcb.12.6.2662-2672.1992
The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP
Abstract
The CD19 protein is expressed on the surface of all B-lymphoid cells with the exception of terminally differentiated plasma cells and has been implicated as a signal-transducing receptor in the control of proliferation and differentiation. Here we demonstrate complete correlation between the expression pattern of the CD19 gene and the B-cell-specific transcription factor BSAP in a large panel of B-lymphoid cell lines. The human CD19 gene has been cloned, and several BSAP-binding sites have been mapped by in vitro protein-DNA binding studies. In particular, a high-affinity BSAP-binding site instead of a TATA sequence is located in the -30 promoter region upstream of a cluster of heterogeneous transcription start sites. Moreover, this site is occupied by BSAP in vivo in a CD19-expressing B-cell line but not in plasma or HeLa cells. This high-affinity site has been conserved in the promoters of both human and mouse CD19 genes and was furthermore shown to confer B-cell specificity to a beta-globin reporter gene in transient transfection experiments. In addition, BSAP was found to be the only abundant DNA-binding activity of B-cell nuclear extracts that interacts with the CD19 promoter. Together, this evidence strongly implicates BSAP in the regulation of the CD19 gene.
Similar articles
-
Regulation of mouse CD72 gene expression during B lymphocyte development.J Immunol. 1998 Nov 1;161(9):4760-7. J Immunol. 1998. PMID: 9794407
-
The transcription factor B-cell-specific activator protein is not involved in the IL-4-induced activation of the human IgE germline promoter.J Immunol. 1996 Aug 15;157(4):1538-43. J Immunol. 1996. PMID: 8759736
-
The Ah receptor recognizes DNA binding sites for the B cell transcription factor, BSAP: a possible mechanism for dioxin-mediated alteration of CD19 gene expression in human B lymphocytes.Biochem Biophys Res Commun. 1995 Jul 6;212(1):27-34. doi: 10.1006/bbrc.1995.1931. Biochem Biophys Res Commun. 1995. PMID: 7541987
-
The role of BSAP (Pax-5) in B-cell development.Curr Opin Genet Dev. 1995 Oct;5(5):595-601. doi: 10.1016/0959-437x(95)80028-x. Curr Opin Genet Dev. 1995. PMID: 8664547 Review.
-
B cell differentiation: role of E2A and Pax5/BSAP transcription factors.Oncogene. 1995 Aug 3;11(3):413-26. Oncogene. 1995. PMID: 7630627 Review.
Cited by
-
Pax5 Negatively Regulates Osteoclastogenesis through Downregulation of Blimp1.Int J Mol Sci. 2021 Feb 20;22(4):2097. doi: 10.3390/ijms22042097. Int J Mol Sci. 2021. PMID: 33672551 Free PMC article.
-
A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage.J Clin Invest. 1996 Oct 1;98(7):1519-26. doi: 10.1172/JCI118943. J Clin Invest. 1996. PMID: 8833898 Free PMC article.
-
CluGene: A Bioinformatics Framework for the Identification of Co-Localized, Co-Expressed and Co-Regulated Genes Aimed at the Investigation of Transcriptional Regulatory Networks from High-Throughput Expression Data.PLoS One. 2013 Jun 18;8(6):e66196. doi: 10.1371/journal.pone.0066196. Print 2013. PLoS One. 2013. PMID: 23823315 Free PMC article.
-
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies.Cell. 2020 Oct 1;183(1):126-142.e17. doi: 10.1016/j.cell.2020.08.022. Epub 2020 Sep 21. Cell. 2020. PMID: 32961131 Free PMC article.
-
PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma.Neoplasia. 2024 Oct;56:101035. doi: 10.1016/j.neo.2024.101035. Epub 2024 Aug 2. Neoplasia. 2024. PMID: 39096792 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases